CORT Q2 2022 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$103M+12.9% YoY

Gross Profit

$102M98.7% margin

Operating Income

$31M30.4% margin

Net Income

$27M26.5% margin

EPS (Diluted)

$0.24

QoQ Revenue Growth

+10.4%

Cash Flow

Operating Cash Flow

$18M

Free Cash Flow

$18M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$496M

Total Liabilities

$54M

Stockholders' Equity

$442M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$103M	$92M	+12.9%
Gross Profit	$102M	$90M	+13.2%
Operating Income	$31M	$32M	-1.6%
Net Income	$27M	$27M	+3.4%